Key Highlights

  • The selloff started with the biggest insurers on Monday, November 16.
  • Smaller managed-care and health services names were dragged down too.
  • CMS Administrator Oz framed the rule as a Fraud crackdown.
  • The market was split, with small caps outperforming overall.

The spark: a proposed CMS rule

The selling started with the giants. On Monday, November 16, the Centers for Medicare & Medicaid Services proposed a rule it calls CRUSH, short for "Comprehensive Regulations to Uncover Suspicious Healthcare." The proposal would let CMS extrapolate Medicare Advantage risk adjustment audit findings from a sample of records to an entire contract, starting with payment year 2018. CMS estimates about $90 billion in savings over 10 years. The rule is not final, and comments are due January 19, 2027.

CMS Administrator Dr. Mehmet Oz framed the proposal as a way to "crush fraud, waste, and abuse."

The big names took the first hit

On Wednesday, November 18, the second straight day of selling, UnitedHealth Group (NYSE:UNH) tumbled and was the worst performer in the Dow Jones Industrial Average. Humana (NYSE:HUM) sank further still and was the worst stock in the S&P 500. Medicare Advantage made up $99.4 billion of Humana's $129.7 billion in 2025 revenue, making it the most exposed of the large insurers. Elevance Health (NYSE:ELV), Centene (NYSE:CNC), CVS Health (NYSE:CVS), Cigna (NYSE:CI) and Molina Healthcare (NYSE:MOH) also slid.

The Dow fell 561.25 points to 50,198.17, and health care stocks pushed it to its session low. Health care was the second-worst S&P 500 sector, behind energy.

How it reached smaller stocks

The pressure did not stop at the large caps. Oscar Health (NYSE:OSCR), a mid-cap insurer outside the S&P 500, fell with the managed-care selloff, and no company-specific news was identified. Astrana Health (NASDAQ:ASTH), a small-cap company that works with physician groups in value-based care, also slid. No company news was found for Astrana either, and it moved with the managed-care and Medicare Advantage selloff.

Ardent Health (NYSE:ARDT), a hospital operator, tumbled as well. In its case, there was a company-specific event alongside the sector weakness: Ardent priced a secondary offering of 8 million shares at $14.50, upsized from 7 million, along with a concurrent repurchase of 1.5 million shares. Other health services names, including PACS Group (NYSE:PACS) and RadNet, also slipped, with no company-specific catalyst identified.

When a policy proposal targets how a whole program pays, investors often reprice companies that depend on that program's money flow, not just the insurers named in headlines. That pattern was consistent with Wednesday's moves.

A split market

The health care slide stood out on a day when smaller stocks broadly did well. The Russell 2000 rose 12.44 points to 2,714.31, and the S&P SmallCap 600 and S&P MidCap 400 also gained. The S&P 500 slipped 16.90 points to 7,323.63, its fifth straight loss, while the Nasdaq Composite added 101.50 points to 24,429.88.

How a Federal Proposal Reached Smaller Health Stocks

The next formal step is the January 19, 2027, comment deadline. Oppenheimer expects legal challenges and has said plans would price the cost into their bids. The proposal revives a 2023 rule that a Texas federal judge vacated in September 2025 in a case brought by Humana. UnitedHealth is expected to give its 2027 outlook before year-end, a possible read-through for the broader group.